These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9160267)

  • 1. High-performance liquid chromatographic assay of dilazep in plasma after solid-phase extraction.
    Gumieniczek A; Przyborowski L
    J Pharm Biomed Anal; 1997 Apr; 15(7):997-1000. PubMed ID: 9160267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive method for determination of nicorandil in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Tanikawa M; Uzu M; Ohsawa Y; Fukushima M
    J Chromatogr; 1993 Jul; 617(1):163-7. PubMed ID: 8376532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
    Chen J; Cai J; Tao W; Mei N; Cao S; Jiang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):201-6. PubMed ID: 16321580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amrinone and N-acetylamrinone assay in human plasma using solid-phase extraction and reversed-phase chromatography.
    Laganière S; Goernert L
    J Pharm Biomed Anal; 1994 Mar; 12(3):407-11. PubMed ID: 8031942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection.
    Hüttmann A; Mross K; Hossfeld DK
    J Chromatogr; 1993 Oct; 620(2):233-8. PubMed ID: 8300791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid determination of minoxidil in human plasma using ion-pair HPLC.
    Zarghi A; Shafaati A; Foroutan SM; Khoddam A
    J Pharm Biomed Anal; 2004 Oct; 36(2):377-9. PubMed ID: 15496332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance analysis of a reversed-phase liquid chromatographic assay of lamotrigine in plasma using solvent-demixing extraction.
    Cociglio M; Alric R; Bouvier O
    J Chromatogr; 1991 Dec; 572(1-2):269-76. PubMed ID: 1818061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ng rivanol in human plasma by SPE-HPLC method.
    Guo Z; Wei D; Gan N; Xie H; Yu X
    J Chromatogr Sci; 2007 Jul; 45(6):325-9. PubMed ID: 17626720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a method for the quantitation of Delta9 tetrahydrocannabinol in human plasma by high performance liquid chromatography after solid-phase extraction.
    Abbara C; Galy R; Benyamina A; Reynaud M; Bonhomme-Faivre L
    J Pharm Biomed Anal; 2006 Jun; 41(3):1011-6. PubMed ID: 16500063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of apovincaminic acid in serum by means of high-performance liquid chromatography.
    Kraus G; Schulz HU; Lohmann A
    J Chromatogr; 1992 Jan; 573(2):323-7. PubMed ID: 1601968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of nicorandil in plasma using high-performance liquid chromatography with photoconductivity and ultraviolet detection. Application to pre-clinical pharmacokinetics in beagle dogs.
    Schwende FJ; Lewis RC
    J Chromatogr; 1990 Jan; 525(1):151-60. PubMed ID: 2140114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection.
    Loregian A; Pagni S; Ballarin E; Sinigalia E; Parisi SG; Palù G
    J Pharm Biomed Anal; 2006 Oct; 42(4):500-5. PubMed ID: 16765009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma.
    Nannetti G; Pagni S; Parisi SG; Alberti A; Loregian A; Palù G
    J Pharm Biomed Anal; 2016 Mar; 121():197-203. PubMed ID: 26808069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple and rapid HPLC-UV method for the determination of retigabine in human plasma.
    Franco V; Baruffi K; Gatti G; Marchiselli R; Fattore C; Canevini MP; Crema F; Perucca E
    Biomed Chromatogr; 2018 May; 32(5):e4168. PubMed ID: 29235121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New method for the chiral evaluation of mirtazapine in human plasma by liquid chromatography.
    de Santana FJ; Cesarino EJ; Bonato PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):351-6. PubMed ID: 15315787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a method for the determination of cefovecin in plasma by HPLC.
    Cox S; Martin A; Hamill M; Pistole N; Steeil J; Schumacher J
    Biomed Chromatogr; 2014 Aug; 28(8):1126-30. PubMed ID: 24420236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of myrislignan in rat plasma by solid-phase extraction and reversed-phase high-performance liquid chromatography.
    Li F; Yang X
    Biomed Chromatogr; 2008 Jun; 22(6):601-5. PubMed ID: 18254153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic assay for sematilide in plasma using solid-phase extraction microcolumn technology.
    Laganière S; Goernert L; Beatch G
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):191-5. PubMed ID: 7858714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of picotamide in human plasma and urine by high-performance liquid chromatography.
    Fossati T; Parisi S; Abbiati G; Castiglioni C
    J Chromatogr; 1992 Jun; 577(2):382-6. PubMed ID: 1400771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of (R)- and (S)-brefanolol in human plasma: high-performance liquid chromatographic assay on a chiral stationary phase.
    Neubeck M; Henke D; Spahn-Langguth H; Mutschler E
    Arch Pharm (Weinheim); 1994 Mar; 327(3):193-6. PubMed ID: 8179478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.